Atlas banks $400 million in its latest 'breakthrough biotech' fund
If there's anything this pandemic has taught us, it's that biotech — and its investors — will not be stopped. With a $400 million raise, Atlas Venture is the latest VC shop to close a major fund since the World Health Organization officially declared COVID-19 a pandemic, joining the likes of Arch, Flagship and Deerfield.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063